[Syntropy of malignant diseases with hemoblastosis].
D000230:Adenocarcinoma / Q000139:chemically induced / Q000150:complications* / Q000601:surgery; D000368:Aged; D002066:Busulfan / Q000009:adverse effects; D004958:Estradiol / Q000009:adverse effects; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D007680:Kidney Neoplasms / Q000139:chemically induced / Q000150:complications* / Q000601:surgery; D009378:Neoplasms, Multiple Primary / Q000209:etiology*; D009381:Neoplasms, Radiation-Induced; D009392:Nephrectomy; D055728:Primary Myelofibrosis / Q000150:complications*; D013739:Testosterone / Q000009:adverse effects; D014594:Uterine Neoplasms / Q000150:complications* / Q000532:radiotherapy / Q000601:surgery; D014631:Valerates / Q000009:adverse effects
D007166:Immunosuppressive Agents; D014631:Valerates; D013739:Testosterone; D004958:Estradiol; D002066:Busulfan
Syntropie von zwei malignen Erkrankungen mit einer Hämoblastose.